INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Mankind Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543904	ISIN Demat INE634S01028	Book Value 354.72	NSE Symbol MANKIND	Dividend Yield (%) 0	Market Cap (₹ Cr.) 108,481.62	P/E 59.94	EPS 43.85	Face Value 1

Particulars (₹ Cr)	Jun 2025	Mar 2025	Dec 2024	Sep 2024

Gross Sales/Income from operations	2541.36	2126.59	2414.41	2529.74
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,541.36	2,126.59	2,414.41	2,529.74
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	2,541.36	2,126.59	2,414.41	2,529.74
Total Expenses	1,965.22	1,754.91	1,759.42	1,863.13
Cost of Sales	669.64	557.48	654.37	703.37
Employee Cost	584.87	536.75	530.68	525.86
Depreciation, amortization and depletion expense	96.93	105.24	91.11	85.42
Provisions & Write Offs	0.00	15.82	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	613.78	539.62	483.26	548.48
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	576.14	371.68	654.99	666.61
Other Income	64.22	219.32	70.37	105.76
Profit from ordinary activities before finance costs and exceptional items	640.36	591.00	725.36	772.37
Finance Costs	146.70	162.25	200.27	1.92
Profit from ordinary activities after finance costs but before exceptional items	493.66	428.75	525.09	770.45
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	493.66	428.75	525.09	770.45
Total Tax	80.90	46.29	113.07	168.01
Net profit from Ordinary Activities After Tax	412.76	382.46	412.02	602.44
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	31.99
Net profit from Ordinary Activities/Discontinued Operations After Tax	412.76	382.46	412.02	634.43
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	412.76	382.46	412.02	634.43
Other Comprehensive Income	1.06	-3.27	9.41	0.17
Total Comprehensive Income	413.82	379.19	421.43	634.60
Equity	41.26	41.26	40.06	40.06
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	10.00	9.27	10.35	15.84
EPS before Exceptional/Extraordinary items-Diluted	9.99	9.25	10.33	15.81
EPS after Exceptional/Extraordinary items-Basic	10.00	9.27	10.35	15.84
EPS after Exceptional/Extraordinary items-Diluted	9.99	9.25	10.33	15.81
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	1.00	0.00	0.00	0.00
Dividend (%)	100.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.46	0.50	0.00	0.00
Debt Service Coverage Ratio	0.76	0.12	0.00	0.00
Interest Service Coverage Ratio	3.93	2.29	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00